New one-dose treatment edits a gene in the liver, disabling the ANGPTL3 protein and significantly lowers cholesterol.

The FDA has approved Fesilty (fibrinogen, human-chmt) for the treatment of acute bleeding episodes in pediatric and adult patients with congenital fibrinogen deficiency (CFD), including hypo- or ...

To better support their employee base and help cut costs, healthcare benefit platform Angle Health partnered with specialty ...

Chimeric antigen receptor (CAR) T-cell therapy-associated immune-related adverse events (CirAEs) were associated with a high ...

High-priced treatments, administered in expensive facilities, are becoming one of the largest cost drivers within ...

Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine—which designs nanotechnology-based ...

MyMichigan Medical Center Gladwin has added four new infusion therapy chairs to enhance patient comfort, funded by a $24,000 donation from the MyMichigan Health Foundation.

Serenity Mental Health Centers, a leader in psychiatric care and one of the fastest growing mental health providers in the ...

Key points A 75-year-old woman presented to the emergency department with acute confusion and lethargy on the third day of ...

During a live event, Omid Hamid, MD, discussed the logistics and multidisciplinary process of using tumor-infiltrating ...

The Advanced Cancer Center and Care Complex is expected to open in 2029 with 120 physicians and 400 staff members serving ...

Bringing regenerative medicine, longevity science, and advanced mental-health therapies to the Great Lakes Bay Region ...